BCTX
Briacell Therapeutics
BCTX
BCTX
17 hedge funds and large institutions have $19.4M invested in Briacell Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 18 → 17 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
17
Holding in Top 10
1
Calls
$7.55M
Puts
–
Top Buyers
| 1 | +$1.56M | |
| 2 | +$498K | |
| 3 | +$228K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$109K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$107K |
Top Sellers
| 1 | -$2.39M | |
| 2 | -$186K | |
| 3 | -$89K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$60.2K |
| 5 |
N
Natixis
Paris,
France
|
-$56.3K |